Cargando…
Host Defense Peptides as Templates for Antifungal Drug Development
Current treatment for invasive fungal diseases is limited to three classes of antifungal drugs: azoles, polyenes, and echinocandins. The most recently introduced antifungal class, the echinocandins, was first approved nearly 30 years ago. The limited antifungal drug portfolio is rapidly losing its c...
Autores principales: | Basso, Virginia, Tran, Dat Q., Ouellette, André J., Selsted, Michael E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711597/ https://www.ncbi.nlm.nih.gov/pubmed/33113935 http://dx.doi.org/10.3390/jof6040241 |
Ejemplares similares
-
A host-directed macrocyclic peptide therapeutic for MDR gram negative bacterial infections
por: Schaal, Justin B., et al.
Publicado: (2021) -
Rhesus Theta Defensin 1 Promotes Long Term Survival in Systemic Candidiasis by Host Directed Mechanisms
por: Basso, Virginia, et al.
Publicado: (2019) -
Do Mast Cells Contribute to the Antifungal Host Defense?
por: Żelechowska, Paulina, et al.
Publicado: (2021) -
Host Defense Peptide-Mimicking Polymers and Polymeric-Brush-Tethered Host Defense Peptides: Recent Developments, Limitations, and Potential Success
por: Etayash, Hashem, et al.
Publicado: (2021) -
T-cell Subsets and Antifungal Host Defenses
por: van de Veerdonk, Frank L., et al.
Publicado: (2010)